Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Reduction in Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Ameet Patel, MD, Karina L Wilkerson, NP, MSN, Kathryn A. Culos, PharmD, Jennifer Green, MD, Michael T. Byrne, DO, Salyka M. Sengsayadeth, MD, Bhagirathbhai Dholaria, MBBS, Bipin N. Savani, MD, Stacey Ann Goodman, MD, Wichai Chinratanalab, MD, Reena Jayani, MD, Katie S. Gatwood, PharmD, Brian G. Engelhardt, MD, Adetola A. Kassim, MDMS

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-138499

Published: 2020

Journal Articles

Increased Incidence of New-Onset Diabetes Mellitus Type II Following Haploidentical Bone Marrow Transplant with Post-Transplant Cyclophosphamide for Sickle Cell Disease

Dilan A Patel, MD, Josu de la Fuente, Michael Matheney, MD, Leena Karnik, FRCPath, MRCP, Heidi Chen, PhD, Katie S. Gatwood, PharmD, Kathryn A. Culos, PharmD, Karina L Wilkerson, NP, MSN, Michael T. Byrne, DO, Salyka M. Sengsayadeth, MD, Stacey Ann Goodman, MD, Bhagirathbhai Dholaria, MBBS, Bipin N. Savani, MD, Wichai Chinratanalab, MD, Reena Jayani, MD, Jim Connelly, MD, Carrie Kitko, MD, Brian G. Engelhardt, MD, Adetola A. Kassim, MDMS

Blood (2020) 136 (Supplement 1): 20.

https://doi.org/10.1182/blood-2020-143039

Published: 2020

Journal Articles

Reduced Insulin Sensitivity in Patients with Myeloid Malignancies and Clonal Hematopoiesis Mutations

Uttam K. Rao, MD MBA, Heidi Chen, PhD, Katie S. Gatwood, PharmD, Michael T. Byrne, DO, Salyka M. Sengsayadeth, MD, Stacey A. Goodman, MD, Bhagirathbhai Dholaria, MBBS, Adetola A. Kassim, MDMS, Bipin N. Savani, MD, Wichai Chinratanalab, MD, Kathryn A. Culos, PharmD, Michael R. Savona, MD, Brian G. Engelhardt, MD

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-137712

Published: 2020

Journal Articles

Venetoclax-Based Salvage Therapy for Post-Hematopoietic Cell Transplantation Relapse in Acute Myeloid Leukemia

Michael T Byrne, DO, Nathalie Danielson, MSN, Adrianne Rasche, MSN, Rachel Hammers, MSN, Kathryn A Culos, PharmD, Katie S Gatwood, PharmD, Houston Wyatt, PharmD, Kristin Fogo, BSN, Bhagirathbhai Dholaria, MBBS, Brian G Engelhardt, MD, Paul Brent Ferrell, Jr., MD, Madan Jagasia, MBBS, MS, MMHC, Adetola A. Kassim, MDMS, Sanjay R Mohan, MD MSCI, Bipin N. Savani, MD, Stephen A. Strickland, MD, Salyka M. Sengsayadeth, MD, Michael R. Savona, MD

Blood (2019) 134 (Supplement_1): 2643.

https://doi.org/10.1182/blood-2019-129146

Published: 2019

Journal Articles

Outcomes of a Novel Rituximab-Based Non-Ablative Conditioning Regimen for Hematopoietic Cell Transplantation in Severe Aplastic Anemia

Katie S Gatwood, PharmD, Kathryn A Culos, PharmD, Laura A Binari, MD, Brian G Engelhardt, MD, Adetola A. Kassim, MD MS, Michael Byrne, MD, Stacey A Goodman, MD MS, Wichai Chinratanalab, MD, Salyka M. Sengsayadeth, MD, John P. Greer, MD, Madan Jagasia, MD MBBS, MS, Bipin N. Savani, MD

Blood (2017) 130 (Supplement 1): 3210.

https://doi.org/10.1182/blood.V130.Suppl_1.3210.3210

Published: 2017

Journal Articles

Reduced Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes When Compared to Fludarabine and Busulfan Following Allogeneic Hematopoietic Cell Transplantation for Lymphoid Malignancies

Vanessa E Kennedy, BS, Bipin N. Savani, MD, John P. Greer, MD, Adetola A. Kassim, MD MS, Brian G Engelhardt, MD, Stacey A. Goodman, MD MS, Salyka M. Sengsayadeth, MD, Wichai Chinratanalab, MD, Madan H. Jagasia

Blood (2015) 126 (23): 4409.

https://doi.org/10.1182/blood.V126.23.4409.4409

Published: 2015

Journal Articles

Optimizing Anti-Thymocyte Globulin Dosing Based on Recipient Absolute Lymphocyte Count after Unrelated Allogeneic Hematopoietic Cell Transplant

Vanessa E Kennedy, BS, Heidi Chen, Bipin N. Savani, MD, John P. Greer, MD, Adetola A. Kassim, MD MS, Brian G Engelhardt, MD, Stacey A. Goodman, MD MS, Salyka M. Sengsayadeth, MD, Wichai Chinratanalab, MD, Madan H. Jagasia

Blood (2015) 126 (23): 4410.

https://doi.org/10.1182/blood.V126.23.4410.4410

Published: 2015

Journal Articles

Six Month Freedom From Steroid Failure Complements Day 28 Response to Steroids As a Predictor of Survival After Acute Graft-Versus-Host Disease Treatment

Salyka M. Sengsayadeth, MD, Madan Jagasia, MBBS, MS, John P. Greer, MD, Heidi Chen, PhD, Stacey Goodman, MD, Wichai Chinratanalab, MD, Adetola A Kassim, MD, Bipin N. Savani, MD, Brian G Engelhardt, MD, MSCI

Blood (2012) 120 (21): 4187.

https://doi.org/10.1182/blood.V120.21.4187.4187

Published: 2012

NARROW

Reduction in Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Increased Incidence of New-Onset Diabetes Mellitus Type II Following Haploidentical Bone Marrow Transplant with Post-Transplant Cyclophosphamide for Sickle Cell Disease

Reduced Insulin Sensitivity in Patients with Myeloid Malignancies and Clonal Hematopoiesis Mutations

Venetoclax-Based Salvage Therapy for Post-Hematopoietic Cell Transplantation Relapse in Acute Myeloid Leukemia

Outcomes of a Novel Rituximab-Based Non-Ablative Conditioning Regimen for Hematopoietic Cell Transplantation in Severe Aplastic Anemia

Reduced Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes When Compared to Fludarabine and Busulfan Following Allogeneic Hematopoietic Cell Transplantation for Lymphoid Malignancies

Optimizing Anti-Thymocyte Globulin Dosing Based on Recipient Absolute Lymphocyte Count after Unrelated Allogeneic Hematopoietic Cell Transplant

Six Month Freedom From Steroid Failure Complements Day 28 Response to Steroids As a Predictor of Survival After Acute Graft-Versus-Host Disease Treatment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only